Ozempic has taken the world by storm, transforming from a diabetes drug to a weight-loss sensation and now a potential treatment for a whole range of diseases.
On this episode of IC Your Trade, host Pamela Ambler speaks to Novo Holdings’ Managing Partner and Head of Asia Dr Amit Kakar about turning diabetes drug profits into solutions for global health challenges.
